Supplemental materials of Psychiatric Safety Associated with Naltrexone-Bupropion in Obesity Treatment: Insights from FDA Adverse Events Reporting System.
Published: 17 October 2024| Version 1 | DOI: 10.17632/xr7nt8k58b.1
Contributors:
Nan Chen, , Description
This dataset is the supplemental data of manuscript titled "Psychiatric Safety Associated with Naltrexone-Bupropion in Obesity Treatment: Insights from FDA Adverse Events Reporting System."
Files
Institutions
Shenzhen Second People's Hospital
Categories
Drug Adverse Reactions, Pharmacovigilance